The anti-inflammatory and organ protective effect of Teprenone

The anti-inflammatory and organ protective effect of Teprenone - The anti-inflammatory and organ protective effect of Teprenone

Status

Active, not recruiting

Phases

Unknown

Study type

Interventional

Source

JPRN

Registry ID

JPRN-UMIN000011401

Enrollment

Registered

2013-08-15

Start date

2013-08-15

Completion date

Unknown

Last updated

2026-06-29

For informational purposes only — not medical advice. Sourced from public registries and may not reflect the latest updates. Terms

Conditions

perioperative patient(malignant tumor, rheumatism, maitenance dyalisis, administration of steroids are excluded)

Interventions

Administration of Teprenone Control(No medication)

Eligibility

Sex/Gender

All

Inclusion criteria

Inclusion criteria: peri operative patient

Exclusion criteria

Exclusion criteria: maintenance hemodyalisis, malignant tumor, administration of steroids, rheumatism

Design outcomes

Primary

Measure	Time frame
Serum CRP, WBC, AST, ALT, BUN, Crea, IL-6, IL-8 and TNF-alpha of blood sample in pre operation, post operation, 1,3 and 6th day after operation.	—

Countries

Japan

Outcome results

None listed

Source: JPRN (via WHO ICTRP) · Data processed: Jul 3, 2026